Its first fund of $10 million, backed by the JSW family office, included investments in companies like Purplle, HealthPlix, and HomeLane. The fund delivered 3X returns, including a 2.7X return from its exit in Purplle in 2023.
Cureskin, an AI-driven dermatology platform that provides clinically validated skin & hair health solutions, has raised Series B funding of USD 20 million.